Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Ge, Yongpeng ^a   Lu, Xin ^a   Shu, Xiaoming ^a   Peng, Qinglin ^a   Wang, Guochun ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; COMPLICATION; DERMATOMYOSITIS; DYSPHAGIA; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MUSCLE WEAKNESS; ONSET AGE; PATHOLOGY; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHINA; DEGLUTITION DISORDERS; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; UBIQUITIN-ACTIVATING ENZYMES;

EID: 85027967799     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00240-6     Document Type: Article

References (15)

1. Ghirardello, A. et al. Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 15, 335 (2013).
2. Casciola-Rosen, L. & Mammen, A. L. Myositis autoantibodies. Curr Opin Rheumatol 24, 602-8 (2012).
3. Betteridge, Z., Gunawardena, H., North, J., Slinn, J. & McHugh, N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum 56, 3132-7 (2007).
4. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis 68, 1621-5 (2009).
5. Tarricone, E., Ghirardello, A., Rampudda, M., Bassi, N., Punzi, L. & Doria, A. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 31, 128-34 (2012).
6. Fujimoto, M. et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 72, 151-3 (2013).
7. Muro, Y., Sugiura, K. & Akiyama, M. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 46, 279-84 (2013).
8. Bodoki, L., Nagy-Vincze, M., Griger, Z., Betteridge, Z., Szöllosi, L. & Dankó, K. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 13, 1211-9 (2014).
9. Muro, Y., Sugiura, K., Nara, M., Sakamoto, I., Suzuki, N. & Akiyama, M. High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis. R heumatology (Oxford) 54, 1745-7 (2015).
10. Fujimoto, M. et al. Myositis-Specific Anti-155/140 Autoantibodies Target Transcription Intermediary Factor 1 Family Proteins. Arthritis Rheum. 64, 513-22 (2012).
11. Fiorentino, D. F. et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. Arthritis Rheum 65, 2954-62 (2013).
12. Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292, 344-7 (1975).
13. Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292, 403-7 (1975).
14. Rider, L. G. et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62, 465-72 (2010).
15. Sultan, S. M. et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50, 2281-90 (2004).